Arbutamine hydrochloride

This classification denotes a beta-adrenergic agonist with the molecular formula C18H23NO4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K0NF2CPJ7F, chemically known as 1,2-benzenediol, 4-(1-hydroxy-2-((4-(4-hydroxyphenyl)butyl)amino)ethyl)-, (r)-, hydrochloride but more generally known as arbutamine hydrochloride, which bears US NIH Compound Identifier 166551. The base compound, Arbutamine, most often comes in base and hydrochloride forms. European Medicines Agency schedules Arbutamine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00570MIG. Most nations, for tariff and trade purposes, schedule arbutamine hydrochloride under HS 29225000 and SITC 51467. As of Q4 2014, ARBUTAMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Arbutamine hydrochloride bears US NLM identifiers UMLS ID C0772148 and NCI Concept Code C65239. SMILES: C1CC(CCC1CCCCNC[C@@H](C2CCC(C(C2)O)O)O)O.CL.